Brief: Cutia Therapeutics Posts FY Loss Attributable RMB1.96 Billion
27/03/2024 10:30
March 27 (Reuters) - Cutia Therapeutics 2487.HK :
* FY LOSS ATTRIBUTABLE RMB1.96 BILLION VERSUS LOSS OF
RMB555.8
MILLION
* FY REVENUE UP 1,110.8% TO RMB137.6 MILLION
Further company coverage: 2487.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cutia Therapeutics
See all newsBrief: Cutia Therapeutics To Implement Share Repurchase Program From Oct 2 To Dec 31
Brief: Cutia Therapeutics Says Cu-40102 Bags Marketing Approval From Macao Pharmaceutical Administration Bureau
Brief: Cutia Therapeutics Says Nmpa Accepts Biologics License Application For Cu-20101
Brief: Cutia Therapeutics Posts HY Loss Of RMB180.4 MLN
Brief: Cutia Therapeutics Says CU-30101 Obtains Drug Marketing Authorization By NMPA China